Shizuya Yamashita

Shizuya Yamashita's AcademicInfluence.com Rankings

Shizuya Yamashita

Computer Science

#6625

World Rank

#6983

Historical Rank

Machine Learning

#2214

World Rank

#2242

Historical Rank

Artificial Intelligence

#2483

World Rank

#2524

Historical Rank

Database

#3706

World Rank

#3858

Historical Rank

computer-science Degrees

Download Badge

Computer Science

Shizuya Yamashita's Degrees

PhD Computer Science Imperial University of Japan
Masters Computer Science Kyoto University
Bachelors Computer Science Osaka University

Similar Degrees You Can Earn

Why Is Shizuya Yamashita Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Shizuya Yamashita's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. (1999) (4901)
Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. (2000) (3235)
Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin. (1999) (1813)
Adiponectin, an Adipocyte-Derived Plasma Protein, Inhibits Endothelial NF-&kgr;B Signaling Through a cAMP-Dependent Pathway (2000) (1707)
Visfatin: a protein secreted by visceral fat that mimics the effects of insulin. (2005) (1380)
Adipocyte-Derived Plasma Protein, Adiponectin, Suppresses Lipid Accumulation and Class A Scavenger Receptor Expression in Human Monocyte-Derived Macrophages (2001) (1025)
Enhanced expression of PAI–1 in visceral fat: Possible contributor to vascular disease in obeisty (1996) (932)
Abdominal fat: standardized technique for measurement at CT. (1999) (821)
Visfatin: A Protein Secreted by Visceral Fat That Mimics the Effects of Insulin (2005) (763)
An adipocyte-derived plasma protein, adiponectin, adheres to injured vascular walls. (2000) (587)
Waist circumference as a vital sign in clinical practice: a Consensus Statement from the IAS and ICCR Working Group on Visceral Obesity (2020) (528)
Visceral and ectopic fat, atherosclerosis, and cardiometabolic disease: a position statement. (2019) (449)
Japan Atherosclerosis Society (JAS) Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases 2017 (2018) (421)
Genomic structure and mutations in adipose-specific gene, adiponectin (2000) (389)
Reduced uptake of oxidized low density lipoproteins in monocyte-derived macrophages from CD36-deficient subjects. (1995) (338)
Clinical Genetic Testing for Familial Hypercholesterolemia: JACC Scientific Expert Panel. (2018) (321)
Other types of primary hyperlipoproteinemia(hyperlipidemia). Executive summary of the Japan Atherosclerosis Society (JAS) guidelines for the diagnosis and prevention of atherosclerotic cardiovascular diseases in Japan--2012 version. (2013) (312)
Effect of visceral fat accumulation on uric acid metabolism in male obese subjects: visceral fat obesity is linked more closely to overproduction of uric acid than subcutaneous fat obesity. (1998) (293)
Defining severe familial hypercholesterolaemia and the implications for clinical management: a consensus statement from the International Atherosclerosis Society Severe Familial Hypercholesterolemia Panel. (2016) (292)
Executive summary of the Japan Atherosclerosis Society (JAS) guidelines for the diagnosis and prevention of atherosclerotic cardiovascular diseases in Japan -2012 version. (2014) (283)
Integrated guidance on the care of familial hypercholesterolaemia from the International FH Foundation. (2014) (262)
Genetic cholesteryl ester transfer protein deficiency is extremely frequent in the Omagari area of Japan. Marked hyperalphalipoproteinemia caused by CETP gene mutation is not associated with longevity. (1997) (262)
Visceral fat accumulation as an important risk factor for obstructive sleep apnoea syndrome in obese subjects (1997) (245)
Angiopoietin-Like Protein3 Regulates Plasma HDL Cholesterol Through Suppression of Endothelial Lipase (2006) (205)
Oxidized LDL-induced NF-kappa B activation and subsequent expression of proinflammatory genes are defective in monocyte-derived macrophages from CD36-deficient patients. (2000) (201)
Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. 1999. (2012) (190)
Atherosclerotic disease in marked hyperalphalipoproteinemia. Combined reduction of cholesteryl ester transfer protein and hepatic triglyceride lipase. (1995) (185)
Accumulation of apolipoprotein E-rich high density lipoproteins in hyperalphalipoproteinemic human subjects with plasma cholesteryl ester transfer protein deficiency. (1990) (183)
Coronary artery disease. Executive summary of the Japan Atherosclerosis Society (JAS) guidelines for the diagnosis and prevention of atherosclerotic cardiovascular diseases in Japan--2012 version. (2014) (181)
Insulin Resistance and Body Fat Distribution: Contribution of visceral fat accumulation to the development of insulin resistance and atherosclerosis (1996) (181)
CD36, a novel receptor for oxidized low-density lipoproteins, is highly expressed on lipid-laden macrophages in human atherosclerotic aorta. (1999) (179)
Identification of Unique Lipoprotein Subclasses for Visceral Obesity by Component Analysis of Cholesterol Profile in High-Performance Liquid Chromatography (2005) (173)
Expression of human scavenger receptor class B type I in cultured human monocyte-derived macrophages and atherosclerotic lesions. (1999) (172)
Aquaporin Adipose, a Putative Glycerol Channel in Adipocytes* (2000) (167)
Report of the Japan Atherosclerosis Society (JAS) Guideline for Diagnosis and Treatment of Hyperlipidemia in Japanese adults. (2002) (167)
Localization of heparin-binding EGF-like growth factor in the smooth muscle cells and macrophages of human atherosclerotic plaques. (1995) (167)
Where are we with probucol: a new life for an old drug? (2009) (165)
Guidelines for the management of familial hypercholesterolemia. (2012) (163)
Integrated guidance on the care of familial hypercholesterolaemia from the International FH Foundation (2015) (162)
CD36 deficiency associated with insulin resistance (2001) (153)
Role of LCAT in HDL remodeling: investigation of LCAT deficiency states Published, JLR Papers in Press, December 20, 2006. (2007) (151)
Pathophysiology of human genetic CD36 deficiency. (2003) (151)
Studies on the impaired metabolism of uric acid in obese subjects: marked reduction of renal urate excretion and its improvement by a low-calorie diet. (1986) (150)
Two decades of annual medical examinations in Japanese obese children: Do obese children grow into obese adults? (1997) (148)
Overview of the current status of familial hypercholesterolaemia care in over 60 countries - The EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC). (2018) (147)
Increased plasma cholesteryl ester transfer protein in obese subjects. A possible mechanism for the reduction of serum HDL cholesterol levels in obesity. (1994) (147)
Molecular biology and pathophysiological aspects of plasma cholesteryl ester transfer protein. (2000) (145)
Adiponectin accelerates reverse cholesterol transport by increasing high density lipoprotein assembly in the liver. (2007) (141)
Large and cholesteryl ester-rich high-density lipoproteins in cholesteryl ester transfer protein (CETP) deficiency can not protect macrophages from cholesterol accumulation induced by acetylated low-density lipoproteins. (1994) (138)
Diagnostic criteria for dyslipidemia. (2013) (137)
Enhanced expression of rat obese (ob) gene in adipose tissues of ventromedial hypothalamus (VMH)-lesioned rats. (1995) (135)
A missense mutation in the cholesteryl ester transfer protein gene with possible dominant effects on plasma high density lipoproteins. (1993) (133)
Guidelines for Diagnosis and Treatment of Familial Hypercholesterolemia 2017 (2018) (132)
Integrated guidance on the care of familial hypercholesterolemia from the International FH Foundation. (2014) (131)
Physiological and pathological roles of a multi-ligand receptor CD36 in atherogenesis; insights from CD36-deficient patients (2007) (128)
Effects of K-877, a novel selective PPARα modulator (SPPARMα), in dyslipidaemic patients: A randomized, double blind, active- and placebo-controlled, phase 2 trial. (2016) (123)
Increased lipid rafts and accelerated lipopolysaccharide-induced tumor necrosis factor-α secretion in Abca1-deficient macrophagess⃞ Published, JLR Papers in Press, November 7, 2006. (2007) (117)
Magnitude of sustained multiple risk factors for ischemic heart disease in Japanese employees: a case-control study. (2001) (110)
Oxidized LDL increases and interferon-gamma decreases expression of CD36 in human monocyte-derived macrophages. (1998) (109)
Decrease in intra-abdominal visceral fat may reduce blood pressure in obese hypertensive women. (1996) (107)
Characterization of plasma lipoproteins in patients heterozygous for human plasma cholesteryl ester transfer protein (CETP) deficiency: plasma CETP regulates high-density lipoprotein concentration and composition. (1991) (106)
Effects of Pemafibrate, a Novel Selective PPARα Modulator, on Lipid and Glucose Metabolism in Patients With Type 2 Diabetes and Hypertriglyceridemia: A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Trial (2018) (106)
Thiazolidinedione derivative improves fat distribution and multiple risk factors in subjects with visceral fat accumulation--double-blind placebo-controlled trial. (2001) (105)
Adiponectin and other adipocytokines as predictors of markers of triglyceride-rich lipoprotein metabolism. (2005) (105)
Small polydisperse low density lipoproteins in familial hyperalphalipoproteinemia with complete deficiency of cholesteryl ester transfer activity. (1988) (105)
Visceral fat is a major contributor for multiple risk factor clustering in Japanese men with impaired glucose tolerance. (2001) (103)
Lipoprotein(a) enhances the expression of intercellular adhesion molecule-1 in cultured human umbilical vein endothelial cells. (1998) (103)
Molecular mechanisms of cholesteryl ester transfer protein deficiency in Japanese. (2004) (103)
Visceral fat accumulation contributes to insulin resistance, small-sized low-density lipoprotein, and progression of coronary artery disease in middle-aged non-obese Japanese men. (2001) (102)
Molecular mechanisms, lipoprotein abnormalities and atherogenicity of hyperalphalipoproteinemia. (2000) (96)
Efficacy and safety of pemafibrate (K-877), a selective peroxisome proliferator-activated receptor α modulator, in patients with dyslipidemia: Results from a 24-week, randomized, double blind, active-controlled, phase 3 trial. (2017) (96)
Effects of evolocumab (AMG 145), a monoclonal antibody to PCSK9, in hypercholesterolemic, statin-treated Japanese patients at high cardiovascular risk--primary results from the phase 2 YUKAWA study. (2014) (96)
Expression of macrophage (Mphi) scavenger receptor, CD36, in cultured human aortic smooth muscle cells in association with expression of peroxisome proliferator activated receptor-gamma, which regulates gain of Mphi-like phenotype in vitro, and its implication in atherogenesis. (2000) (95)
Vascular endothelial dysfunction resulting from L-arginine deficiency in a patient with lysinuric protein intolerance. (2001) (95)
Matrix Metalloproteinases as Novel Disease Markers in Takayasu Arteritis (2003) (93)
Increased lipid rafts and accelerated lipopolysaccharide-induced tumor necrosis factor-alpha secretion in Abca1-deficient macrophages. (2007) (91)
Pros and cons of inhibiting cholesteryl ester transfer protein (2000) (91)
Long-term probucol treatment prevents secondary cardiovascular events: a cohort study of patients with heterozygous familial hypercholesterolemia in Japan. (2008) (90)
Clinical features of familial hypercholesterolemia in Japan in a database from 1996-1998 by the research committee of the ministry of health, labour and welfare of Japan. (2004) (87)
CD36 mediates long-chain fatty acid transport in human myocardium: Complete myocardial accumulation defect of radiolabeled long-chain fatty acid analog in subjects with CD36 deficiency (1999) (86)
Pooling and expanding registries of familial hypercholesterolaemia to assess gaps in care and improve disease management and outcomes: Rationale and design of the global EAS Familial Hypercholesterolaemia Studies Collaboration. (2016) (85)
Enhanced expression of hepatic acyl‐coenzyme A synthetase and microsomal triglyceride transfer protein messenger RNAs in the obese and hypertriglyceridemic rat with visceral fat accumulation (1998) (84)
Ezetimibe improves postprandial hyperlipidaemia in patients with type IIb hyperlipidaemia (2009) (84)
The selective peroxisome proliferator-activated receptor alpha modulator (SPPARMα) paradigm: conceptual framework and therapeutic potential (2019) (84)
Molecular mechanisms of HDL-cholesterol elevation by statins and its effects on HDL functions. (2010) (83)
Efficacy and safety of K-877, a novel selective peroxisome proliferator-activated receptor α modulator (SPPARMα), in combination with statin treatment: Two randomised, double-blind, placebo-controlled clinical trials in patients with dyslipidaemia. (2017) (83)
Selective reduction of cholesterol in HDL2 fraction by probucol in familial hypercholesterolemia and hyperHDL2 cholesterolemia with abnormal cholesteryl ester transfer. (1988) (82)
Detection of two species of low density lipoprotein particles in cholesteryl ester transfer protein deficiency. (1991) (82)
Ezetimibe Lipid-Lowering Trial on Prevention of Atherosclerotic Cardiovascular Disease in 75 or Older (EWTOPIA 75): A Randomized Controlled Trial. (2019) (82)
Decreased microsomal triglyceride transfer protein activity contributes to initiation of alcoholic liver steatosis in rats. (2002) (81)
HDL/apolipoprotein A-I binds to macrophage-derived progranulin and suppresses its conversion into proinflammatory granulins. (2010) (81)
Diagnosis and management of type I and type V hyperlipoproteinemia. (2012) (81)
Angptl 4 deficiency improves lipid metabolism, suppresses foam cell formation and protects against atherosclerosis. (2009) (78)
Dominant expression of ATP-binding cassette transporter-1 on basolateral surface of Caco-2 cells stimulated by LXR/RXR ligands. (2002) (77)
Localization of heparin-binding epidermal growth factor-like growth factor in human coronary arteries. Possible roles of HB-EGF in the formation of coronary atherosclerosis. (1996) (76)
Deletion of progranulin exacerbates atherosclerosis in ApoE knockout mice. (2013) (75)
Betacellulin and Amphiregulin Induce Upregulation of Cyclin D1 and DNA Synthesis Activity Through Differential Signaling Pathways in Vascular Smooth Muscle Cells (2003) (74)
Pemafibrate, a New Selective PPARα Modulator: Drug Concept and Its Clinical Applications for Dyslipidemia and Metabolic Diseases (2020) (74)
Matrix metalloproteinases as novel disease markers in Takayasu arteritis. (2004) (72)
Current therapy for patients with sitosterolemia--effect of ezetimibe on plant sterol metabolism. (2010) (71)
Troglitazone suppresses intimal formation following balloon injury in insulin-resistant Zucker fatty rats. (1998) (70)
Plasma apolipoprotein L concentrations correlate with plasma triglycerides and cholesterol levels in normolipidemic, hyperlipidemic, and diabetic subjects. (2000) (70)
C-Terminal Tails of Sulfonylurea Receptors Control ADP-Induced Activation and Diazoxide Modulation of ATP-Sensitive K+ Channels (2000) (69)
Increased plasma HB-EGF associated with obesity and coronary artery disease. (2002) (69)
Efficacy and Safety of Pemafibrate Versus Fenofibrate in Patients with High Triglyceride and Low HDL Cholesterol Levels: A Multicenter, Placebo-Controlled, Double-Blind, Randomized Trial (2018) (68)
Global perspective of familial hypercholesterolaemia: a cross-sectional study from the EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC) (2021) (68)
Decreased affinity of low density lipoprotein (LDL) particles for LDL receptors in patients with cholesteryl ester transfer protein deficiency (1995) (67)
Expression of cholesteryl ester transfer protein in human atherosclerotic lesions and its implication in reverse cholesterol transport. (2001) (66)
Impaired insulin secretion in four Tangier disease patients with ABCA1 mutations. (2009) (65)
Prevalence and phenotypic spectrum of cholesteryl ester transfer protein gene mutations in Japanese hyperalphalipoproteinemia. (2003) (65)
Large scale isolation of non-uniform shear stress-responsive genes from cultured human endothelial cells through the preparation of a subtracted cDNA library. (2002) (64)
Aggregated Ursolic Acid, a Natural Triterpenoid, Induces IL-1β Release from Murine Peritoneal Macrophages: Role of CD361 (2007) (63)
Familial hypercholesterolaemia: evolving knowledge for designing adaptive models of care (2020) (63)
High concentration of glucose induces the expression of intercellular adhesion molecule-1 in human umbilical vein endothelial cells. (1998) (62)
Low-density lipoprotein cholesterol levels and lipid-modifying therapy prescription patterns in the real world: An analysis of more than 33,000 high cardiovascular risk patients in Japan. (2016) (60)
Marked hyper-HDL2-cholesterolemia associated with premature corneal opacity. A case report. (1984) (59)
TTC39B Deficiency Stabilizes LXR Reducing both Atherosclerosis and Steatohepatitis (2016) (58)
Postprandial Hyperlipidemia and Remnant Lipoproteins (2017) (57)
Liver fat reduction with niacin is influenced by DGAT-2 polymorphisms in hypertriglyceridemic patients (2012) (57)
Effect of weight loss on markers of triglyceride‐rich lipoprotein metabolism in the metabolic syndrome (2008) (57)
Recent Advances in Analytical Methods on Lipoprotein Subclasses: Calculation of Particle Numbers from Lipid Levels by Gel Permeation HPLC Using "Spherical Particle Model". (2016) (56)
Frequency of exon 15 missense mutation (442D:G) in cholesteryl ester transfer protein gene in hyperalphalipoproteinemic Japanese subjects. (1995) (56)
Correlation of fasting serum apolipoprotein B‐48 with coronary artery disease prevalence (2012) (55)
Interferon α induces disorder of lipid metabolism by lowering postheparin lipases and cholesteryl ester transfer protein activities in patients with chronic hepatitis C (1997) (55)
Two novel missense mutations in the CETP gene in Japanese hyperalphalipoproteinemic subjects DOI 10.1194/jlr.M200024-JLR200 (2002) (55)
Adiponectin deficiency suppresses ABCA1 expression and ApoA‐I synthesis in the liver (2007) (55)
Polydisperse low-density lipoproteins in hyperalphalipoproteinemic chronic alcohol drinkers in association with marked reduction of cholesteryl ester transfer protein activity. (1992) (55)
Proposed guidelines for hypertriglyceridemia in Japan with non-HDL cholesterol as the second target. (2008) (53)
High‐density lipoproteins from probucol‐treated patients have increased capacity to promote cholesterol efflux from mouse peritoneal macrophages loaded with acetylated low‐density lipoproteins (1997) (53)
Total deficiency of plasma cholesteryl ester transfer protein in subjects homozygous and heterozygous for the intron 14 splicing defect. (1990) (53)
Guidance for Pediatric Familial Hypercholesterolemia 2017 (2018) (52)
Decreased expression of a member of the Rho GTPase family, Cdc42Hs, in cells from Tangier disease – the small G protein may play a role in cholesterol efflux (2000) (52)
Development of a homogeneous assay to measure remnant lipoprotein cholesterol. (2007) (52)
Enhanced myocardial glucose use in patients with a deficiency in long-chain fatty acid transport (CD36 deficiency). (1999) (52)
Comparison of visibility and diagnostic capability of noninvasive coronary angiography by eight-slice multidetector-row computed tomography versus conventional coronary angiography. (2004) (51)
Activation of monocytes in vivo causes intracellular accumulation of lipoprotein-derived lipids and marked hypocholesterolemia--a possible pathogenesis of necrobiotic xanthogranuloma. (1999) (49)
Frequency of intron 14 splicing defect of cholesteryl ester transfer protein gene in the Japanese general population--relation between the mutation and hyperalphalipoproteinemia. (1993) (48)
Exon 10 skipping caused by intron 10 splice donor site mutation in cholesteryl ester transfer protein gene results in abnormal downstream splice site selection. (1996) (48)
The expression of SPARC in adipose tissue and its increased plasma concentration in patients with coronary artery disease. (2001) (47)
Adiponectin prevents atherosclerosis by increasing cholesterol efflux from macrophages. (2008) (47)
Lipid Accumulation in Smooth Muscle Cells Under LDL Loading Is Independent of LDL Receptor Pathway and Enhanced by Hypoxic Conditions (2002) (47)
Cloning and functional expression of a novel isoform of ROMK inwardly rectifying ATP‐dependent K+ channel, ROMK6 (Kir1.1 f) (1996) (45)
Decrease of hepatic triglyceride lipase levels and increase of cholesteryl ester transfer protein levels in patients with primary biliary cirrhosis: Relationship to abnormalities in high‐density lipoprotein (1993) (45)
Fasting serum apolipoprotein B-48 can be a marker of postprandial hyperlipidemia. (2011) (44)
Multicenter study to determine the diagnosis criteria of heterozygous familial hypercholesterolemia in Japan. (2012) (43)
Troglitazone enhances glucose uptake and inhibits mitogen-activated protein kinase in human aortic smooth muscle cells. (1998) (43)
Comprehensive risk management for the prevention of cardiovascular disease: executive summary of the Japan Atherosclerosis Society (JAS) guidelines for the diagnosis and prevention of atherosclerotic cardiovascular diseases in Japan -- 2012. (2013) (43)
Probucol Enhances the Expression of Human Hepatic Scavenger Receptor Class B Type I, Possibly Through a Species-Specific Mechanism (2005) (42)
Molecular mechanisms of ezetimibe-induced attenuation of postprandial hypertriglyceridemia. (2010) (42)
Roles of plasma lipid transfer proteins in reverse cholesterol transport. (2001) (42)
Did we abandon probucol too soon? (2015) (41)
Molecular genetics of plasma cholesteryl ester transfer protein. (1997) (41)
A novel nonsense mutation (G181X) in the human cholesteryl ester transfer protein gene in Japanese hyperalphalipoproteinemic subjects. (1996) (40)
Translational Research for Improving the Care of Familial Hypercholesterolemia: The "Ten Countries Study" and Beyond. (2016) (40)
Lipoprotein abnormalities in human genetic CD36 deficiency associated with insulin resistance and abnormal fatty acid metabolism. (2003) (39)
A Novel Selective PPARα Modulator (SPPARMα), K-877 (Pemafibrate), Attenuates Postprandial Hypertriglyceridemia in Mice (2017) (39)
Adiponectin deficiency suppresses ABCA1 expression and ApoA-I synthesis in the liver. (2008) (39)
Clinical Applications of a Novel Selective PPARα Modulator, Pemafibrate, in Dyslipidemia and Metabolic Diseases (2019) (38)
Long-Term Efficacy and Safety of Pemafibrate, a Novel Selective Peroxisome Proliferator-Activated Receptor-α Modulator (SPPARMα), in Dyslipidemic Patients with Renal Impairment (2019) (38)
Patients with CD36 deficiency are associated with enhanced atherosclerotic cardiovascular diseases. (2012) (36)
Pharmacokinetics and metabolism of 123I-BMIPP fatty acid analog in healthy and CD36-deficient subjects. (2000) (36)
Asia-Pacific Consensus Statement on the Management of Peripheral Artery Disease (2020) (35)
Characteristics of coronary artery disease and lipoprotein abnormalities in patients with heterozygous familial hypercholesterolemia associated with diabetes mellitus or impaired glucose tolerance. (1997) (35)
Importance of intra-abdominal visceral fat accumulation to coronary atherosclerosis in heterozygous familial hypercholesterolaemia (1997) (35)
Hypocholesterolaemic factor from gallbladder cancer cells (1990) (35)
Autoimmune hyperchylomicronemia. (1989) (35)
Disappearance of intraglomerular lipoprotein thrombi and marked improvement of nephrotic syndrome by bezafibrate treatment in a patient with lipoprotein glomerulopathy. (2003) (34)
Mutations in Japanese subjects with primary hyperlipidemia--results from the Research Committee of the Ministry of Health and Welfare of Japan since 1996--. (2004) (34)
An enquiry based on a standardised questionnaire into knowledge, awareness and preferences concerning the care of familial hypercholesterolaemia among primary care physicians in the Asia-Pacific region: the “Ten Countries Study” (2017) (33)
Homogeneous Assays for LDL-C and HDL-C are Reliable in Both the Postprandial and Fasting State (2017) (33)
Novel LPL mutation (L303F) found in a patient associated with coronary artery disease and severe systemic atherosclerosis (2003) (33)
Serum apolipoprotein B-48 levels are correlated with carotid intima-media thickness in subjects with normal serum triglyceride levels. (2011) (32)
Role of membrane-anchored heparin-binding epidermal growth factor-like growth factor and CD9 on macrophages. (1997) (31)
Effects of pemafibrate (K-877) on cholesterol efflux capacity and postprandial hyperlipidemia in patients with atherogenic dyslipidemia. (2018) (31)
RECS1 deficiency in mice induces susceptibility to cystic medial degeneration. (2006) (31)
Expression and functional analyses of novel mutations of ATP-binding cassette transporter-1 in Japanese patients with high-density lipoprotein deficiency. (2002) (31)
Ectopic expression of alpha1,6 fucosyltransferase in mice causes steatosis in the liver and kidney accompanied by a modification of lysosomal acid lipase. (2001) (30)
Immunohistochemical localization of Betacellulin, a member of epidermal growth factor family, in atherosclerotic plaques of human aorta. (2001) (30)
Serum adiponectin level is correlated with the size of HDL and LDL particles determined by high performance liquid chromatography. (2012) (29)
The Effect of Intensive Glucose Lowering on Lipoprotein Particle Profiles and Inflammatory Markers in the Veterans Affairs Diabetes Trial (VADT) (2013) (29)
Distribution of human plasma PLTP mass and activity in hypo- and hyperalphalipoproteinemia DOI 10.1194/jlr.M100349-JLR200 (2002) (29)
Interferon Alpha Induces Disorder of Lipid Metabolism by Lowering Postheparin Lipases and Cholesteryl Ester Transfer Protein Activities in Patients With Chronic Hepatitis C (1998) (29)
Comparative aspects of the care of familial hypercholesterolemia in the "Ten Countries Study". (2019) (28)
Efficacy and safety of pemafibrate in people with type 2 diabetes and elevated triglyceride levels: 52‐week data from the PROVIDE study (2019) (28)
Fasting plasma insulin level is an important risk factor for the development of complications in Japanese obese children--results from a cross-sectional and a longitudinal study. (1995) (28)
Effects of a novel selective peroxisome proliferator‐activated receptor‐α modulator, pemafibrate, on hepatic and peripheral glucose uptake in patients with hypertriglyceridemia and insulin resistance (2018) (27)
Progranulin plays crucial roles in preserving bone mass by inhibiting TNF-α-induced osteoclastogenesis and promoting osteoblastic differentiation in mice. (2015) (27)
Very High Density Lipoproteins Induced by Plasma Cholesteryl Ester Transfer Protein (CETP) Have a Potent Antiatherogenic Function a (1994) (27)
High index of microcirculatory resistance level after successful primary percutaneous coronary intervention can be improved by intracoronary administration of nicorandil. (2010) (27)
Transplantation of human adipose tissue-derived multilineage progenitor cells reduces serum cholesterol in hyperlipidemic Watanabe rabbits. (2011) (27)
Effect of probucol on antioxidant properties of HDL in patients with heterozygous familial hypercholesterolemia. (2012) (26)
Apolipoprotein E plays crucial roles in maintaining bone mass by promoting osteoblast differentiation via ERK1/2 pathway and by suppressing osteoclast differentiation via c-Fos, NFATc1, and NF-κB pathway. (2018) (26)
Acute ST-segment elevation myocardial infarction is associated with decreased human antimicrobial peptide LL-37 and increased human neutrophil peptide-1 to 3 in plasma. (2012) (26)
Integrated guidance on the care of familial hypercholesterolaemia from the International FH Foundation: executive summary. (2014) (26)
Marked hypocholesterolemia in a case with adrenal adenoma--enhanced catabolism of low density lipoprotein (LDL) via the LDL receptors of tumor cells. (1995) (25)
Establishment of chemiluminescence enzyme immunoassay for apolipoprotein B-48 and its clinical applications for evaluation of impaired chylomicron remnant metabolism. (2012) (25)
Apolipoprotein B-48 as a determinant of endothelial function in obese subjects with type 2 diabetes mellitus: effect of fenofibrate treatment. (2012) (25)
Point Mutation (−69 G→A) in the Promoter Region of Cholesteryl Ester Transfer Protein Gene in Japanese Hyperalphalipoproteinemic Subjects (2001) (24)
Expression of CD36 by Olfactory Receptor Cells and Its Abundance on the Epithelial Surface in Mice (2015) (24)
Distal protection during primary coronary intervention can preserve the index of microcirculatory resistance in patients with acute anterior ST-segment elevation myocardial infarction. (2011) (24)
Association of serum apolipoprotein B48 level with the presence of carotid plaque in type 2 diabetes mellitus. (2008) (24)
Retarded Intracellular Lipid Transport Associated With Reduced Expression of Cdc42, a Member of Rho-GTPases, in Human Aged Skin Fibroblasts: A Possible Function of Cdc42 in Mediating Intracellular Lipid Transport (2002) (23)
Rapid enhancement of acyl-CoA synthetase, LPL, and GLUT-4 mRNAs in adipose tissue of VMH rats. (1996) (23)
Localization of CD36 and scavenger receptor class A in human coronary arteries--a possible difference in the contribution of both receptors to plaque formation. (2001) (22)
Diagnosis of atherosclerosis. Executive Summary of the Japan Atherosclerosis Society (JAS) Guidelines for the Diagnosis and Prevention of Atherosclerotic Cardiovascular Diseases in Japan―2012 Version. (2014) (22)
RECS1 is a negative regulator of matrix metalloproteinase-9 production and aged RECS1 knockout mice are prone to aortic dilation. (2006) (22)
Recent advances in synthetic pharmacotherapies for dyslipidaemias (2019) (22)
Localization of CD9, an enhancer protein for proheparin-binding epidermal growth factor-like growth factor, in human atherosclerotic plaques: possible involvement of juxtacrine growth mechanism on smooth muscle cell proliferation. (2000) (21)
Bis(Monoacylglycero)Phosphate Accumulation in Macrophages Induces Intracellular Cholesterol Redistribution, Attenuates Liver-X Receptor/ATP-Binding Cassette Transporter A1/ATP-Binding Cassette Transporter G1 Pathway, and Impairs Cholesterol Efflux (2013) (21)
Significance of measuring serum concentrations of remnant lipoproteins and apolipoprotein B-48 in fasting period. (2009) (21)
Re-evaluation of cholesteryl ester transfer protein function in atherosclerosis based upon genetics and pharmacological manipulation (2016) (21)
Efficacy and Safety of Pemafibrate, a Novel Selective Peroxisome Proliferator-Activated Receptor α Modulator (SPPARMα): Pooled Analysis of Phase 2 and 3 Studies in Dyslipidemic Patients with or without Statin Combination (2019) (21)
Accelerated Atherogenicity in Tangier Disease (2018) (20)
Rivaroxaban Suppresses the Progression of Ischemic Cardiomyopathy in a Murine Model of Diet-Induced Myocardial Infarction (2019) (20)
Cholesteryl ester transfer protein: An enigmatic pharmacology - Antagonists and agonists. (2018) (20)
Acute accumulation of free cholesterol induces the degradation of perilipin 2 and Rab18-dependent fusion of ER and lipid droplets in cultured human hepatocytes (2016) (20)
Probucol Trial for Secondary Prevention of Atherosclerotic Events in Patients with Coronary Heart Disease (PROSPECTIVE) (2020) (20)
Diagnosis of Atherosclerosis (2014) (19)
Two novel missense mutations in the CETP gene in Japanese hyperalphalipoproteinemic subjects: high-throughput assay by Invader ® assay (2002) (19)
Treatment A) lifestyle modification: executive summary of the Japan Atherosclerosis Society(JAS) guidelines for the diagnosis and prevention of atherosclerotic cardiovascular diseases in Japan--2012 version. (2013) (19)
Reference Intervals of Serum Non-Cholesterol Sterols by Gender in Healthy Japanese Individuals (2020) (19)
Effects of a Dipeptidyl Peptidase 4 Inhibitor Sitagliptin on Glycemic Control and Lipoprotein Metabolism in Patients with Type 2 Diabetes Mellitus (GLORIA Trial) (2017) (19)
Lipoprotein Subfractions Highly Associated With Renal Damage in Familial Lecithin: Cholesterol Acyltransferase Deficiency (2014) (18)
Minocycline for the treatment of Takayasu arteritis. (2005) (18)
Efficacy and Safety of Long-term Coadministration of Fenofibrate and Ezetimibe in Patients with Combined Hyperlipidemia: Results of the EFECTL Study (2017) (18)
Low-density lipoproteins in hyperalphalipoproteinemic heavy alcohol drinkers have reduced affinity for the low-density lipoprotein receptor. (1992) (18)
Cloning and functional expression of a novel isoform of ROMK inwardly rectifying ATP-dependent K+ channel, ROMK6 (Kir1.1f). (1996) (17)
Myocardial energy provision is preserved by increased utilization of glucose and ketone bodies in CD36 knockout mice. (2015) (17)
Erratum: Long-Term Probucol Treatment Prevents Secondary Cardiovascular Events: a Cohort Study of Patients with Heterozygous Familial Hypercholesterolemia in Japan [Journal of Atherosclerosis and Thrombosis 1506 292-303] (2009) (17)
Atorvastatin markedly improves type III hyperlipoproteinemia in association with reduction of both exogenous and endogenous apolipoprotein B-containing lipoproteins. (2003) (17)
Diabetes mellitus. Executive summary of the Japan Atherosclerosis Society (JAS) guidelines for the diagnosis and prevention of atherosclerotic cardiovascular diseases in Japan--2012 version. (2014) (16)
Differential reactivities of four homogeneous assays for LDL-cholesterol in serum to intermediate-density lipoproteins and small dense LDL: comparisons with the Friedewald equation. (2009) (16)
Relationship between LDL receptor activity and development of coronary heart disease in Japanese cases with heterozygous familial hypercholesterolemia. (1987) (16)
Defective cholesterol efflux in Werner syndrome fibroblasts and its phenotypic correction by Cdc42, a RhoGTPase (2005) (16)
A 31-year-old woman with homozygous familial hypercholesterolemia without significant lesions in the coronary arteries. (1986) (16)
Diagnosis and Management of Sitosterolemia 2021 (2021) (16)
Molecular Defect and Atherogenicity in Cholesteryl Ester Transfer Protein Deficiency (1994) (16)
Human scavenger receptor class B type I is expressed with cell-specific fashion in both initial and terminal site of reverse cholesterol transport. (2005) (15)
Shotgun proteomic analysis reveals proteome alterations in HDL of patients with cholesteryl ester transfer protein deficiency. (2019) (15)
An atypical case of abetalipoproteinaemia with severe fatty liver in the absence of steatorrhoea or acanthocytosis (2005) (15)
Increased serum remnant lipoproteins in patients with apolipoprotein E7 (apo E Suita). (1997) (15)
Management of type IIb dyslipidemia. (2012) (15)
Genetic analysis of a Japanese cerebrotendinous xanthomatosis family: identification of a novel mutation in the adrenodoxin binding region of the CYP 27 gene. (1996) (15)
A delayed-addition enzyme immunoassay for the relative cholesteryl ester transfer protein mass in patients with deficient plasma cholesteryl ester transfer activity. (1990) (14)
Evaluation of an HPLC method for LDL-cholesterol determination in patients with various lipoprotein abnormalities in comparison with beta-quantification. (2008) (14)
Visceral fat accumulation and vascular complications associated with VMH lesioning of spontaneously non-insulin-dependent diabetic GK rat. (1996) (14)
Tangier disease with continuous massive and longitudinal diffuse calcification in the coronary arteries : demonstration by the sagittal images of intravascular ultrasonography. (2000) (14)
Treatment B) drug therapy: executive summary of the Japan Atherosclerosis Society(JAS) guidelines for the diagnosis and prevention of atherosclerotic cardiovascular diseases in Japan--2012 version. (2013) (14)
Rationale and Design of the PROSPECTIVE Trial: Probucol Trial for Secondary Prevention of Atherosclerotic Events in Patients with Prior Coronary Heart Disease. (2016) (14)
CD36, but not GPR120, is required for efficient fatty acid utilization during endurance exercise (2014) (14)
Statin Intolerance Clinical Guide 2018 (2020) (14)
Reference interval for the apolipoprotein B-48 concentration in healthy Japanese individuals. (2014) (14)
Fenofibrate reduces postprandial hypertriglyceridemia in CD36 knockout mice. (2010) (13)
Early morphologic changes of atherosclerosis induced by ventromedial hypothalamic lesion in the spontaneously diabetic Goto-Kakizaki rat. (1997) (13)
CD 36 mediates long-chain fatty acid transport in human myocardium : Complete myocardial accumulation defect of radiolabeled long-chain fatty acid analog in subjects with CD 36 deficiency (13)
Characterization of low-density lipoproteins from patients with recessive X-linked ichthyosis. (1988) (13)
Autoimmune hyperlipidemia with inhibitory monoclonal antibodies against low density lipoprotein binding to fibroblasts in a case with multiple myeloma. (1997) (13)
Comparison of effects of anagliptin and alogliptin on serum lipid profile in type 2 diabetes mellitus patients (2017) (12)
Identification of a GPI-anchored type HDL-binding protein on human macrophages. (2000) (12)
One-Year Efficacy and Safety of Evolocumab in Japanese Patients　- A Pooled Analysis From the Open-Label Extension OSLER Studies. (2017) (12)
Cardiovascular disease risk factors other than dyslipidemia. Executive summary of the Japan Atherosclerosis Society (JAS) guidelines for the diagnosis and prevention of atherosclerotic cardiovascular diseases in Japan - 2012 version. (2013) (12)
Retraction (2007) (12)
Mutation in bombesin receptor subtype-3 gene is not a major cause of obesity in the Japanese. (2000) (12)
Apolipoprotein B-48 to triglyceride ratio is a novel and useful marker for detection of type III hyperlipidemia after antihyperlipidemic intervention. (2012) (11)
Evaluation of a homogeneous assay for measuring LDL-cholesterol in hyperlipidemic serum specimens. (2008) (11)
Fasting remnant lipoproteins can predict postprandial hyperlipidemia (2012) (11)
Considerable scatter in the relationship between left atrial volume and pressure in heart failure with preserved left ventricular ejection fraction (2020) (11)
Omega-3 fatty acid ethyl esters improve low-density lipoprotein subclasses without increasing low-density lipoprotein-cholesterol levels: A phase 4, randomized study. (2019) (11)
Treatment Patterns and Lipid Profile in Patients with Familial Hypercholesterolemia in Japan (2018) (11)
Increased proportion of plasma apoB-48 to apoB-100 in non-insulin-dependent diabetic rats: contribution of enhanced apoB mRNA editing in the liver. (1995) (11)
Detrimental effects of high-fat diet loading on vascular endothelial function and therapeutic efficacy of ezetimibe and statins in patients with type 2 diabetes. (2016) (11)
High levels of serum lipoprotein(a) in patients with ischemic heart disease with normal coronary angiogram and thromboangiitis obliterans. (1995) (10)
Non-macrophage-related accumulation of cholesterol during probucol treatment in familial hypercholesterolemia: report of two cases. (1992) (10)
Effects of pravastatin on plasma and urinary mevalonate concentrations in subjects with familial hypercholesterolaemia: a comparison of morning and evening administration (1996) (10)
The lipoprotein fraction between VLDL and LDL detected by biphasic agarose gel electrophoresis reflects serum remnant lipoprotein and Lp(a) concentrations. (2006) (10)
Dietary Oxysterol, 7-Ketocholesterol Accelerates Hepatic Lipid Accumulation and Macrophage Infiltration in Obese Mice (2021) (10)
Comparison of eight- versus 16-slice multidetector-row computed tomography for visibility and image quality of coronary segments. (2004) (10)
Association of lifestyle-related factors with circadian onset patterns of acute myocardial infarction: a prospective observational study in Japan (2014) (10)
Familial massive tendon xanthomatosis with decreased high-density lipoprotein-mediated cholesterol efflux. (2005) (10)
Thyroid function influences serum apolipoprotein B-48 levels in patients with thyroid disease. (2012) (9)
Progranulin deficiency leads to enhanced age-related cardiac hypertrophy through complement C1q-induced β-catenin activation. (2019) (9)
Serum apolipoprotein B-48 concentration is associated with a reduced estimated glomerular filtration rate and increased proteinuria. (2014) (9)
Absolute risk of cardiovascular disease and lipid management targets. (2013) (9)
Familial hypercholesterolaemia‐like syndrome with apolipoprotein E‐7 associated with marked Achilles tendon xanthomas and coronary artery disease: a report of two cases (1994) (9)
Remnant lipoprotein-cholesterol is a predictive biomarker for large artery atherosclerosis in apparently healthy women: usefulness as a parameter for annual health examinations (2011) (9)
HMG-CoA reductase inhibitor augments the serum total cholesterol-lowering effect of human adipose tissue-derived multilineage progenitor cells in hyperlipidemic homozygous Watanabe rabbits. (2011) (9)
Treatment B) Drug Therapy (2013) (9)
Effectiveness and Safety of Lipid-Lowering Drug Treatments in Japanese Patients with Familial Hypercholesterolemia: Familial Hypercholesterolemia Expert Forum (FAME) Study (2021) (9)
A role of CD36 in the perception of an oxidised phospholipid species in mice. (2015) (9)
Gaps in beliefs and practice in dyslipidaemia management in Japan, Germany, Colombia and the Philippines: insights from a web-based physician survey (2020) (8)
Pressure Overload Impairs Cardiac Function in Long-Chain Fatty Acid Transporter CD36-Knockout Mice. (2019) (8)
A Pooled Analysis of Pemafibrate Phase II/III Clinical Trials Indicated Significant Improvement in Glycemic and Liver Function-related Parameters (2018) (8)
Effect of Extended-Release Niacin/Laropiprant Combination on Plasma Adiponectin and Insulin Resistance in Chinese Patients with Dyslipidaemia (2015) (8)
Widespread Coronary Dysfunction in the Absence of HDL Receptor SR-B1 in an Ischemic Cardiomyopathy Mouse Model (2017) (8)
Particle number analysis of lipoprotein subclasses by gel permeation HPLC in patients with cholesteryl ester transfer protein deficiency (2018) (8)
Familial hypercholesterolemia. (2014) (8)
Factors Associated with Carotid Atherosclerosis and Achilles Tendon Thickness in Japanese Patients with Familial Hypercholesterolemia: A Subanalysis of the Familial Hypercholesterolemia Expert Forum (FAME) Study (2021) (8)
Effects of pemafibrate on glucose metabolism markers and liver function tests in patients with hypertriglyceridemia: a pooled analysis of six phase 2 and phase 3 randomized double‐blind placebo‐controlled clinical trials (2021) (8)
Current Diagnosis and Management of Tangier Disease (2021) (8)
[HDL and arteriosclerosis]. (1992) (8)
Cell surface-expressed moesin-like HDL/apoA-I binding protein promotes cholesterol efflux from human macrophages Published, JLR Papers in Press, October 26, 2005. (2006) (7)
Abstract 13374: Efficacy and Safety of K-877, a Potent and Selective PPAR-α Modulator (SPPARMα), in Combination With Statins in Japanese Patients With Dyslipidemia (2015) (7)
Apolipoprotein B-100 kinetics and static plasma indices of triglyceride-rich lipoprotein metabolism in overweight men. (2005) (7)
Establishment of a Novel Murine Model of Ischemic Cardiomyopathy with Multiple Diffuse Coronary Lesions (2013) (7)
Relation of Serum Lipoprotein(a) Levels to Lipoprotein and Apolipoprotein Profiles and Atherosclerotic Diseases in Japanese Patients with Heterozygous Familial Hypercholesterolemia: Familial Hypercholesterolemia Expert Forum (FAME) Study (2021) (7)
Molecular disorders of cholesteryl ester transfer protein. (1996) (7)
Reduced adhesion of monocyte-derived macrophages from CD36-deficient patients to type I collagen. (2001) (7)
Effects of Phenotypic and Genotypic Factors on the Lipid Responses to Niacin in Chinese Patients With Dyslipidemia (2015) (7)
Real-World Data to Identify Hypercholesterolemia Patients on Suboptimal Statin Therapy (2019) (6)
A compound heterozygote for familial hypercholesterolaemia with a homozygous mother (1996) (6)
Risk stratification based on metabolic syndrome as well as non- metabolic risk factors in the assessment of carotid atherosclerosis. (2011) (6)
Distinct Differences in Lipoprotein Particle Number Evaluation between GP-HPLC and NMR: Analysis in Dyslipidemic Patients Administered a Selective PPARα Modulator, Pemafibrate (2021) (6)
Abstract 15652: Comparison of the Novel Peroxisome Proliferator-Activated Receptor Alpha Agonist K-877 and Fenofibrate on High-Density Lipoprotein Subclass Distribution Determined by High-Performance Liquid Chromatography in Patients With Dyslipidemia (2013) (5)
Marked effects of novel selective peroxisome proliferator-activated receptor α modulator, pemafibrate in severe hypertriglyceridemia: preliminary report (2020) (5)
Acetylcholine-Induced Coronary Microvascular Vasospasm in a Patient with Angina Pectoris and Normal Coronary Angiogram (1997) (5)
[Microsomal triglyceride transfer protein (MTP)]. (2001) (5)
Does pravastatin increase chylomicron remnant catabolism in postmenopausal women with type 2 diabetes mellitus? (2005) (5)
Senescent phenotypes of skin fibroblasts from patients with Tangier disease. (2007) (5)
Pemafibrate suppresses NLRP3 inflammasome activation in the liver and heart in a novel mouse model of steatohepatitis-related cardiomyopathy (2022) (5)
CD36 involvement in the olfactory perception of oleic aldehyde, an odour-active volatile compound, in mice. (2017) (4)
Immunohistochemical localization of fatty acid transporters and MCT1 in the sebaceous glands of mouse skin. (2016) (4)
Mathematical Modeling of Planar Cell Polarity To (2008) (4)
Pulmonary hypertension associated with bone marrow transplantation. (2010) (4)
Abstract 10718: Efficacy and Safety of K-877, a Potent and Selective PPAR-a Agonist, in Japanese Patients With Dyslipidemia (2013) (4)
Statement for Appropriate Clinical Use of PCSK9 Inhibitors (2018) (4)
[Clinical significance of apolipoprotein B-48 (apoB-48) in patients with thyroid disease]. (2009) (4)
Erratum:A Novel Selective PPARα Modulator (SPPARMα), K-877 (Pemafibrate), Attenuates Postprandial Hypertriglyceridemia in Mice (2018) (3)
Postprandial Glucose and Triglyceride Increases Along with the Endothelial Malfunction were Attenuated by the Administration of SGLT2 Inhibitor, Empagliflozin (2020) (3)
Comprehensive risk management for the prevention of cerebro- cardiovascular diseases in Japan (2017) (3)
Background to discuss guidelines for control of plasma HDL-cholesterol in Japan. (2012) (3)
Impact of the integrated guidance on the care of familial hypercholesterolaemia. (2014) (3)
Cultural Barriers in the Treatment of Dyslipidemia: A Survey of Japanese Physician Attitudes (2019) (3)
Plasma cholesteryl ester transfer protein (CETP) induces very high density lipoproteins (VHDL) with a potent anti-atherogenic function (1994) (3)
Expression of high-density lipoprotein receptors, scavenger receptor class B type I in human central nervous system (2000) (3)
Very High Levels of High-Density Lipoprotein Cholesterol and Cardiovascular Events in Japanese Population. (2016) (3)
[Clinical significance of apolipoprotein B-48 (apoB-48) in chronic kidney disease patients]. (2010) (3)
Abdominal obesity, and not general obesity, is associated with a lower 123I MIBG heart-to-mediastinum ratio in heart failure patients with preserved ejection fraction (2021) (3)
Marked hyperalphalipoproteinemia is not a longevity syndrome. Insights from a cohort study in a city where CETP deficiency accumulates (1994) (3)
DEVELOPMENT AND CLINICAL APPLICATION OF AN ENZYME-LINKED IMMUNOSORBENT ASSAY FOR OXIDIZED HIGH DENSITY LIPOPROTEIN (2020) (3)
A novel molecular basis for genetic cholesteryl ester transfer protein (CETP) deficiency — G to A mutation in consensus ETS binding site at the promoter region of CETP gene (2000) (2)
Correction: Establishment of a Novel Murine Model of Ischemic Cardiomyopathy with Multiple Diffuse Coronary Lesions (2013) (2)
Pharmacokinetics and Metabolism of 123 I-BMIPPFatty Acid Analog in Healthy and CD 36-Deficient Subjects (2006) (2)
Efficacy of Pemafibrate on Atherogenic Dyslipidemia: Results of a Pooled Analysis of Pemafibrate Phase II/III Clinical Trials Compared with Placebo (2018) (2)
Coronary artery bypass grafting for a patient with Tangier disease. (2002) (2)
Clinical and Biochemical Characteristics of Familial Hyperaiphalipoproteinemia Associated with Complete Deficiency of Cholesteryl Ester Transfer Activity (1990) (2)
Long-term Pemafibrate Treatment Was Well Tolerated in Patients with Dyslipidemia Including Those with Kidney Dysfunction (2018) (2)
Validation of Particle Numbers of Lipoproteins by Gel Permeation Chromatography: Comparison with NMR Lipoprofile 2 (LipoScience) and Lipoprofile 3 (LabCorp) (2018) (2)
Low HDL and High HDL Syndromes (2014) (2)
Association of Kidney Function with Serum Levels of Cholesterol Absorption and Synthesis Markers: The CACHE Study CKD Analysis (2022) (2)
Contribution of visceral fat accumulation to the development of atherosclerosis in non-obese subjects (1994) (2)
Reduced Secretion of Tumor Necrosis Factor-α and Interleukin-1β from Monocyte-Derived Macrophages of CD36-Deficient Subjects in Response to Oxidized LDL (2000) (2)
Reduced uptake of oxidized LDL in monocyte-macrophages from CD36-deficient patients (1994) (2)
Mechanism of short term fructose exposure induced chylomicron secretion. (2017) (2)
Other high-risk conditions. (2013) (2)
Abstract 17336: Marked Increase of Plasma Fibroblast Growth Factor 21 in Dyslipidemic Patients Treated With K-877, a Novel Highly Potent and Specific Peroxisome Proliferator-Activated Receptor Alpha Agonist (2013) (2)
Guidelines on the Clinical Evaluation of Medicinal Products for Treatment of Dyslipidemia (2020) (2)
Effects of Selective PPARα Modulator K-877 on Particle Numbers of Lipoprotein Subclasses in Dyslipidemic Patients: Analysis by GP-HPLC and NMR Lipoprofile 2 and 3 (2018) (2)
Abstract 12900: Pressure Overload Induces Hypertrophy and Impaired Cardiac Function in Long-chain Fatty Acid Transporter CD36 Knockout Mice (2013) (2)
CHYLOMICRON REMNANTS ARE INCREASED IN CD36 DEFICIENCY AT POSTPRANDIAL STATE (2008) (2)
A novel adipocyte-derived plasma protein, adiponectin, inhibits endothelial adhesion molecule expression through NF-kB signaling pathway (2000) (2)
Women. Executive Summary of the Japan Atherosclerosis Society (JAS) Guidelines for the Diagnosis and Prevention of Atherosclerotic Cardiovascular Diseases in Japan―2012 Version. (2014) (2)
A novel potent and selective pparalpha agonist, k-877, ameriolates both fasting and postprandial hypertriglyceridemia (2014) (2)
Relation of left atrial overload indices with prognostic endpoints in heart failure and preserved ejection fraction (2022) (2)
W2 A NOVEL HDL-ASSOCIATED PROTEIN, PROGRANULIN, MAY PLAY AN ATHEROPROTECTIVE ROLE BY ENHANCING REVERSE CHOLESTEROL TRANSPORT (2010) (2)
Residual vascular risk in diabetes - Will the SPPARM alpha concept hold the key? (2019) (2)
Anti-GPIHBP1 Antibody-Positive Autoimmune Hyperchylomicronemia and Immune Thrombocytopenia (2022) (2)
Localization of CD 9 , an Enhancer Protein for Proheparin-Binding Epidermal Growth Factor – Like Growth Factor , in Human Atherosclerotic Plaques Possible Involvement of Juxtacrine Growth Mechanism on Smooth Muscle Cell Proliferation (2000) (2)
Efficacy and safety of long-term coadministration of fenofibrate and ezetimibe in patients with combined hyperlipidemia: Results of the efectl trial (2016) (1)
Widespread Coronary Dysfunction in the Absence of HDL Receptor SR-B1 in an Ischemic Cardiomyopathy Mouse Model (2017) (1)
Serum adiponectin levels correlated with serum apolipoprotein b-48 and remnant lipoprotein–cholesterol concentrations and carotid intima-media thickness (2014) (1)
Lipid Composition of Platelet and Red Blood Cell in Patients with Atherosclerotic Disease (II) (1985) (1)
Relationship between Diabetes Mellitus and Serum Lathosterol and Campesterol Levels: The CACHE Study DM Analysis. (2022) (1)
Cerebrovascular diseases: Executive summary of the Japan Atherosclerosis Society (JAS) guidelines for the diagnosis and prevention of atherosclerotic cardiovascular diseases in Japan - 2012 version (2014) (1)
Involvement of decreased expression of a member of Rho GTPases family, CDC42Hs, in the pathophysiology of tangier disease (2000) (1)
Special Report Guidelines for the Management of Familial Hypercholesterolemia (2012) (1)
TTC39B deficiency promotes HDL production and impairs non-hdl absorption in small intestine (2014) (1)
[Fundamental evaluation of apolipoprotein B-48 by chemiluminescence enzyme immunoassay--identification of apolipoprotein B-48 with immunoblotting]. (2007) (1)
Integrated Analysis of Two Probucol Trials for the Secondary Prevention of Atherosclerotic Cardiovascular Events: PROSPECTIVE and IMPACT (2021) (1)
Evolocumab Effects on Lipoproteins, Measured by High-Performance Liquid Chromatography (2020) (1)
Impairment of Reverse Cholesterol Transport System and Atherosclerosis (2000) (1)
Long-Term Treatment With Evolocumab Among Japanese Patients　- Final Report of the OSLER Open-Label Extension Studies. (2019) (1)
A Study of the Regression of Achilles Tendon Xanthoma in Familial Hypercholesterolemia after Long Term Treatment with Drugs by Means of Xeroradiography (1984) (1)
CHARACTERISTICS OF CORONARY HEART DISEASE (CHD) IN FIMILIAL HYPERCHOLESTEROLEMIA (FH) AND ITS INCIDENCE IN FH WITHOUT CLINICAL CARDIAC SYMPTOM : Atherosclerosis : PROCEEDINGS OF THE 50th ANNUAL SCIENTIFIC MEETING OF THE JAPANESE CIRCULATION SOCIETY (1986) (1)
Vesicular Acidification Is Required for ATP-Binding Cassette Transporter A1-Mediated Cholesterol Efflux (2003) (1)
New Horizons for Probucol, an Old, Mysterious Drug (2020) (1)
[Lipid transfer proteins and their functions]. (2007) (1)
A novel adipocyte-derived plasma protein, adiponectin, suppresses lipid accumulation and class a scavenger receptor expression in human macrophages (2000) (1)
[Treatment of high blood cholesterol in patients with coronary heart disease]. (1994) (1)
Fasting Serum Apo B-48 Levels are a Simple and Useful Marker for Postprandial Hyperlipidemia(PH) and Predicts Coronary Heart Disease(CHD) (Lipid Disorders 5 (H), The 69th Annual Scientific Meeting of the Japanese Circulation Society) (2005) (1)
CD36 deficiency and insulin resistance (2001) (1)
Probucol increases hepatic expression of High Density Lipoprotein (HDL) receptor, scavenger receptor class B type I (SR-BI), in vitro and in vivo. — enhancement of reverse cholesterol transport (RCT) (2000) (1)
REGIONAL CEREBRAL OXYGEN SATURATION: A NOVEL INDEX FOR PROMPT CLINICAL OUTCOME PREDICTION BEFORE STARTING EXTRACORPOREAL CARDIOPULMONARY RESUSCITATION IN OUT OF HOSPITAL CARDIAC ARREST PATIENTS (2011) (1)
[Adipocytokines: target for treatment of metabolic syndrome]. (2006) (1)
Association between prognosis and the use of angiotensin‐converting enzyme inhibitors and/or angiotensin II receptor blockers in frail patients with heart failure with preserved ejection fraction (2022) (1)
High-performance gel permeation chromatography analysis demonstrates atherogenic properties of lipoproteins in patients with cholesteryl ester transfer protein deficiency (2016) (1)
Adiposity measures and mortality in an Asian population (2020) (1)
Abstract 16439: Proteomic Analysis of Atherogenic Chylomicron Remnants Isolated Selectively From Human Serum (2016) (1)
Effects of A Novel Acat Inhibitor, F-1394, on the Progression and Regression of Atherosclerotic Lesions in the Aorta of Cholesterol-Fed Rabbits (1996) (1)
Metabolic syndrome. (2020) (1)
Analysis of Various Factors Affecting the Development of Coronary Heart Disease in Familial Hypercholesterolemia (1985) (1)
Evaluation of the efficacy of LAMP-based SARS-CoV-2 detection with simple RNA extraction from nasopharyngeal swabs: A prospective observational study (2021) (1)
IS118 Reduced Secretion of Tumor Necrosis Factor-a and Interleukin-1b from Monocyte-Macrophages of CD36-Deficient Subjects (1999) (1)
Measurement of Cholesterol Efflux from Monocyte-Derived Macrophages of Patients with Llpid Disorders and Atherosclerotic Cardiovascular Diseases (2003) (1)
Familial Hypercholesterolemia and Lipoprotein(a): A Gordian Knot in Cardiovascular Prevention (2022) (1)
Impairment of a protective system against atherosclerosis--genetic disorders in HDL metabolism. (1991) (1)
Application of a sandwich ELISA for apo B48 (2000) (1)
Association between Familial Hypercholesterolemia and Serum Levels of Cholesterol Synthesis and Absorption Markers: The CACHE Study FH Analysis. (2023) (1)
Methods for Studying the Function of Progranulin in Atherosclerosis Using Both Knockout Mice Models and In Vitro Studies. (2018) (1)
Atherogenicity of cholesteryl ester transfer protein deficiency due to consequent lipoprotein abnormalities (1994) (1)
Increased prop ion of plasma apoB-48 to apoB-100 in non-insulin-dependent diabetic rats : contribution of enhanced apoB mRNA e liver ng in the (2002) (1)
A case of hyper-HDL-cholesterolemia with multiple stenoses of coronary artery and arteriosclerosis obliterans (ASO) (1994) (1)
Low HDL/High HDL Syndromes (2004) (1)
Abstract 14993: Proteomic Analysis of Chylomicron Remnants Isolated by Apolipoprotein B-48 Immunoprecipitation (2014) (1)
Significance of cardiac catheterization for asymptomatic patients with familial hypercholesterolemia (1987) (1)
Accumulation of Remnant Lipoprotein-Evaluation and Its Mechanism (1999) (1)
Immunometabolic disorder in cardiovascular system and liver mediated by long-term exposure to diet-derived oxidized cholesterol, 7-ketocholesterol (2020) (0)
EFFECT OF DRUG TREATMENT ON LIPOPROTEIN METABOLISM IN FAMILIAL HYPER-ALPHA-LIPOPROTEINEMIA : Arteriosclerosis : 53 Annual Scientific Meeting, Japanese Circulation Society (1989) (0)
Guidelines for the Diagnosis and Treatment of Adult Familial Hypercholesterolemia 2022. (2023) (0)
A Dietary Oxysterol, 7-Ketocholesterol, Exacerbates Imiquimod-Induced Psoriasis-like Dermatitis in Steatohepatitic Mice (2022) (0)
P300 EFFECT OF PROBUCOL ON AN ANTIOXIDANT PROPERTY OF HDL IN PATIENTS WITH HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA (2010) (0)
Abstract 4547: Intracoronary Administration of Nicorandil Augments the Beneficial Effect of Intravenous Usage on Improvement of Deteriorated Microcirculation in Patients With Acute Myocaridal Infarction (2009) (0)
Low Density Lipoprotein (LDL) Receptors Expressed on a Human Hepatoma Cell Line, Mahlavu (1989) (0)
[Clinical significance of hypolipidemia]. (2007) (0)
Abstract 16836: Ttc39b Deficiency Attenuates Atherosclerosis and Hepatic Steatosis Through Lxrα Dependent Manner (2016) (0)
OE-060 Apo B-48 Is a Good Marker for Coronary Risk and Impaired Metabolism of Chylomicron Remnants in Subjects with Metabolic Syndrome(Lipid disorders-1 (H) OE10,Oral Presentation (English),The 70th Anniversary Annual Scientific Meeting of the Japanese Circulation Society) (2006) (0)
Development of enzyme-linked immunosorbent assay for oxidized high density lipoprotein and its clinical application for cardiovascular risk assessment. (2017) (0)
Abstract 9197: In Situ Stem Cell Therapy Using Human Adipose Tissue-Derived Multi-lineage Progenitor Cells Combined with HMG-CoA Reductase Inhibitor Synergistically Reduce Serum Cholesterol Level in Hyperlipidemic Watanabe Rabbits (2011) (0)
Abstract: P749 SERUM CONCENTRATIONS OF LINOLEIC ACIDS AND THEIR DERIVATIVES BY LIPID PEROXIDATION ARE INCREASED IN PATIENTS WITH CD36 DEFICIENCY (2009) (0)
Relationship between Lipoprotein Fractions and Lipoprotein Lipase and Hepatic Triglyceride Lipase Activities in Postheparin Plasma (1985) (0)
2P-0441 Dominant expression of ATP binding cassette transporter A1 on basolateral surface of human intestinal epithelium (2003) (0)
Th-P16:372 Probucol stabilizes hepatic scavenger receptor class B type I possibly though species-specific fashion (2006) (0)
NanoSPECT imaging reveals the uptake of 123I-labeled oxidized low-density lipoprotein in the brown adipose tissue of mice via CD36. (2022) (0)
Prevalence of low HDL-cholesterol and the metabolic syndrome (2004) (0)
[Primary hyperchylomicronemia]. (2013) (0)
Cholesterol Absorption Inhibitor Ezetimibe: Risk–Benefits and Role in Treating Dyslipidemias (2015) (0)
Analysis of selectively isolated chylomicron remnants in various conditions. (2017) (0)
Development and Clinical Application of an Enzyme-Linked Immunosorbent Assay for Oxidized High-Density Lipoprotein (2020) (0)
GPI-anchored type HDL-binding protein on human monocyte-derived macrophages (2000) (0)
Serum apolipoprotein b-48 concentration are correlated with plaque score of carotid arteries (2014) (0)
Profile Rationale and Design of the PROSPECTIVE Trial : Probucol Trial for Secondary Prevention of Atherosclerotic Events in Patients with Prior Coronary Heart Disease (2016) (0)
Gene regulations of Acyl-CoA synthetase and lipoprotein lipase in intra-abdominal fat and subcutaneous fat (1994) (0)
Abstract: 516 LONG-TERM PROBUCOL TREATMENT PREVENTS CARDIOVASCULAR EVENTS IN CORONARY ARTERY DISEASE PATIENTS WITH HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA (2009) (0)
Lipid Management for Prevention of Atherosclerotic Cardiovascular Diseases (2018) (0)
[Other antihyperlipidemic drugs with novel mechanism]. (2001) (0)
Diet-induced hepatic steatosis and fibrosis were improved by a selective ppara modulator, pemafibrate, in STZ -induced diabetic mice (2021) (0)
Abstract 1099: Adiponectin Enhances De Novo Hepatic HDL Synthesis Through LXR Alpha-and COUP-TFII-Dependent Pathways (2009) (0)
Abstract 12689: Targeted Exon Sequencing of Lipid-related Genes in Patients With Clinically Diagnosed Familial Hypercholesterolemia (2020) (0)
Minocycline Has a Steroid-Sparing Effect in Treatment of Takayasu Arteritis (2002) (0)
The Japan Atherosclerosis Society Guideline for Diagnosis and Managementy of Hyperlipidemia for Precention of Atherosclerosis: ―1998年調査と反応― (1999) (0)
Lipoprotein metabolism and molecular pathogenesis of atherosclerosis (2002) (0)
Title Expression of CD 36 by Olfactory Receptor Cells and ItsAbundance on the Epithelial Surface in Mice (2019) (0)
A familial massive tendon xanthomatosis in association with decreased cholestrol efflux in monocyte-derived macrophages (2000) (0)
patient-oriented and epidemiological research Chylomicron remnants are increased in the postprandial state in CD36 deficiency (2009) (0)
Abstract: P1378 SERUM APOLIPOPROTEIN B-48 LEVEL IS CORRELATED WITH CAROTID INTIMA-MEDIA THICKNESS (IMT) IN SUBJECTS WITH NORMAL SERUM TRIGLYCERIDE LEVEL (2009) (0)
Proatherogenic potentials of genetic deficiency of a major receptor for oxidized LDL, CD36. — A possible candidate gene responsible for multiple risk factor clustering syndrome with insulin resistance (2000) (0)
Abstract 50: A Phase I Clinical Trial Evaluating the Safety of With Allogeneic Adipose Tissue-derived Multilineage Progenitor Cells-transplantation Therapy in Homozygous Familial Hypercholesterolemia Patients (2015) (0)
Serum HDL-Cholesterol Level Does Not Influence Cardiovascular Event Rate under Sufficient Lowering of LDL-Cholesterol by Pitavatatin in Patients with Stable Coronary Artery Disease (2021) (0)
The elderly. (2014) (0)
3P-0865 Minocycline for the treatment of Takayasu arteritis (2003) (0)
Tu-P7:237 Defective cholesterol efflux increased lipid rafts and enhanced lipopolysaccharide-induced cytokine release (2006) (0)
WorkshopIncreased response to heparin-binding EGF-like growth factor (HB-EGF) in vascular smooth muscle cells from streptozotocin-induced diabetic rats (1994) (0)
Expression of Macrophages (Mf) Scavenger receptor, CD36, in cultured human aortic smooth muscle cells, in association with the expression of peroxisome proliferator activated receptor-gamma — gain of Mf-like phenotype in vitro and its implication in atherogenesis (2000) (0)
-0377-PROBUCOL (PB) CHANGES THE CELL POPULATION IN XANTHOMA OF FAMILIAL HYPERCHOLESTEROLEMIA (FH) (1990) (0)
1P-0222 Cdc42, a RhoGTPase, restores defective choleterol efflux in Werner syndrome fibroblasts (2003) (0)
Abstract 395: High-performance Gel Permeation Chromatography Analysis Characterizes Lipoprotein Profiles in Patients with Cholesteryl Ester Transfer Protein Deficiency (2016) (0)
3HT04-2 A shear stress inducible Rho small GTPase strengthens the barrier function of human umbilical vein endothelial cells (HUVECs) and inhibits stress fiber formation (2003) (0)
Abstract 16386: Establishment of Enzyme-Linked Immunosorbent Assay for Oxidized High Density Lipoprotein and its Clinical Application for Cardiovascular Risk Assessment (2016) (0)
1. Frontiers of Laboratory Examination and Treatment of Dyslipidemia (2021) (0)
Th-P15:79 New assay for remnant lipoprotein cholesterol using selective detergents and phospholipase D-clinical significance in postprandial hyperlipidemia (2006) (0)
Abstract 11850: Targeted Next-Generation Sequencing of 36 Lipid-Related Genes in Patients With Clinically Diagnosed Familial Hypercholesterolemia (2021) (0)
2P-0556 Effects of atorvastatin on remnant lipoprotein metabolism in type III hyperlipoproteinemia - comparison with fenofibrate (2003) (0)
Committee Report 14 Cerebrovascular Diseases (2014) (0)
W12.309 Novel ELISA for Apo B-48 revealed chylomicron remnants (CR) are accumulated in the serum of diabetic patients despite normolipidemia (2004) (0)
Abstract 10144: Xcr1 + Dendritic Cell-Induced Cd4 + T Helper-1 Activation Leads to Exacerbation of Remodeling After Myocardial Infarction (2021) (0)
Acute Pancreatitis and Hyperchylomicronetnia (1998) (0)
The role ofCD36 in atherogenesis as a receptor for OxLDL (2000) (0)
Abstract: P926 CLINICAL SIGNIFICANCE OF REMNANT LIPOPROTEIN CHOLESTEROL DETERMINATION IN METABOLIC SYNDROMESTUDIES WITH A NEWLY DEVELOPED HOMOGENOUS ASSAY- (2009) (0)
Correction: fasting remnant lipoproteins can predict postprandial hyperlipidemia (2014) (0)
Effect of Niceritrol on Serum Lipids and Lipoproteins: -Increased Compliance by the Combination Therapy of Aspirin- (1985) (0)
4 Physiological Roles of a Multi-ligand Receptor CD36 in the Metabolic Syndrome and Atherogenesis : Insights from CD36 Deficiency(New Horizons in the Metabolic Syndrome:-Molecular Mechanisms and Therapies,Plenary Session 4 (PL4) (H),The 70th Anniversary Annual Scientific Meeting of the Japanese Circ (2006) (0)
REGIONAL BRAIN OXYGEN SATURATION AS A NOVEL INDEX OF NEUROLOGICAL OUTCOMES IN PATIENTS WITH OUT-OF-HOSPITAL CARDIOGENIC CARDIAC ARREST (2010) (0)
Age-related increase in subjects with multiple coronary risk factors (MRF) is attributed to age-related accumulation of visceral fat (VF) (2002) (0)
Shotgun proteomics analysis characterizes HDL proteome in patients with cholesteryl ester transfer protein deficiency. (2017) (0)
Disorder of lipid metabolism.An advance on diagnosis and treatment.3.Hyperlipidemia and arteriosclerosis.3 HDL and arteriosclerosis. (1992) (0)
Two Cases of Peculiar Hyper-HDL-cholesterolemia Associated with Juvenile Corneal Arcus (1984) (0)
Abstract 20416: Ttc39b Deficiency Has a Beneficial Role on Cholesterol and Triglyceride Absorption in Enterocytes (2014) (0)
[Mechanism and evaluation of lipid metabolism abnormalities and arteriosclerosis--high blood HDL contents]. (2001) (0)
PE-253 Increased Lipid Rafts and Accelerated Lipopolysaccharide-induced Tumor Necrosis Factor α Secretion in Abca1-deficient Macrophages(Lipid disorders-2, The 71st Annual Scientific Meeting of the Japanese Circulation Society) (2007) (0)
Is there a role for niacin in familial hypercholesterolaemia (2015) (0)
Phenotypes of Hyperlipoproteinemia in Japan: -Analysis of 1, 500 Cases in Lipid Research Clinic of Osaka University Hospital-@@@―阪大高脂血症外来通院患者1,500例の検討― (1985) (0)
Minocycline is Effective for Patients with Takayasu Arteritis(Peripheral Circulation/Vascular Disease 5 (H), The 69th Annual Scientific Meeting of the Japanese Circulation Society) (2005) (0)
Abstract 13452: Serum Apolipoprotein B-48 levels Are Significantly Correlated with Plaque Score of Carotid Arteries (2014) (0)
P294 ADIPONECTIN ENHANCES DE NOVO HEPATIC HDL SYNTHESIS THROUGH LXR ALPHA- AND COUP-TFII-DEPENDENT PATHWAYS (2010) (0)
Expression of CD36 in Cultured Human Aortic Smooth Muscle Cells (HASMCs) (2000) (0)
Professor Philip Yu-An Ding 1949-2015. (2016) (0)
PE-159 Familial Intrahepatic Cholestasis 1 (FIC1) Gene Product, a Novel Contributor for Cholesterol Efflux(Atherosclerosis, basic-4 (H) PE27,Poster Session (English),The 70th Anniversary Annual Scientific Meeting of the Japanese Circulation Society) (2006) (0)
Novel ELISA for Apo B-48 Revealed Chylomfcron Remnants (CR) Are Accumulated in the Plasma of Diabetic Patients despite Normolipidemia (2003) (0)
Current status-phase I trial of cell-transplantation therapy with allogeneic adipose tissue-derived multilineage progenitor cells in severe familial hypercholesterolemia patients undergoing LDL-apheresis (2016) (0)
Guidelines for the Diagnosis and Treatment of Pediatric Familial Hypercholesterolemia 2022. (2023) (0)
CD36 Signaling Is Involved in the Regulation of Agonist-Induced Nitric Oxide Production in Human Monocyte-Derived Macrophages (2003) (0)
Abstract: P862 SERUM OXYSTEROL LEVELS ARE ELEVATED IN A PATIENT WITH GIANT NECROTIC TENDON XANTHOMATOSIS AND CAROTID AND CORONARY ATHEROSCLEROSIS (2009) (0)
Juxtacrine Growth Mechanism on Smooth Muscle Cell Proliferation Like Growth Factor, in Human Atherosclerotic Plaques : Possible Involvement of − Factor Localization of CD9, an Enhancer Protein for Proheparin-Binding Epidermal Growth (2000) (0)
In Vitro Effect of Introduction of Cholesterol Efflux-Related Molecules on Lipid Metabolism and Transport in Human Monocytes-Derived Macrophages (2003) (0)
Cell-Surface Expressed Moesin-Like HDL/Apo A-I Binding Protein Is Involved in Cholesterol Efflux from Human Monocyte-derived Macrophages (2002) (0)
-531- STUDIES ON CLINICAL AND BIOCHEMICAL FACTORS WHICH AFFECT THE OCCURRENCE OF CORONARY ARTERY DISEASE (CAD) IN FAMILIAL HYPERCHOLESTEROLEMIA (FH) : INVESTIGATION IN THREE PAIRS OF SIBLINGS (1987) (0)
1P-0252 RECS1, a shear-responsive gene, suppresses Fas-mediated apoptosis (2003) (0)
Rapid Communication Clinical and Biochemical Characteristics of Familial Hyperalphalipoproteinemia Associated with Complete Deficiency of Cholesteryl Ester Transfer Activity* (2011) (0)
[Treatment of high blood cholesterol in patients with coronary heart disease]. (1994) (0)
PE-152 Adiponectin Deficiency Suppresses ABCA1 Expression and ApoA-I Synthesis in the Liver(Atherosclerosis, basic(04)(IHD),Poster Session(English),The 72nd Annual Scientific Meeting of the Japanese Circulation Society) (2008) (0)
WO13-OR-5 ADIPONECTIN PROTECTS AGAINST ATHEROSCLEROSIS BY INCREASING CHOLESTEROL EFFLUX FROM MACROPHAGES (2007) (0)
Abstract: 1508 ADIPONECTIN ENHANCES REVERSE CHOLESTEROL TRANSPORT THROUGH DE NOVO HEPATIC HDL SYNTHESIS AND APOA-IMEDIATED CHOLESTEROL EFFLUX FROM MACROPHAGES VIA ABCA1-DEPENDENT PATHWAY (2009) (0)
PO1-4 ADIPONECTIN ACCELERATES REVERSE CHOLESTEROL TRANSPORT BY INCREASING HDL ASSEMBLY THROUGH UPREGULATION OF ABCA1 PATHWAY AND APOA-I SYNTHESIS IN THE LIVER (2007) (0)
Erratum to “Increased Plasma HB-EGF Associated with Obesity and Coronary Artery Disease” [Biochem. Biophys. Res. Commun. 292 (2002) 781–786] (2002) (0)
Committee Report 16 Women (2014) (0)
[A case of hyper-HDL-cholesterolemia presenting peculiar lipoprotein patterns in agarose gel electrophoresis]. (1989) (0)
Th-P15:121 Development and application of a new assay system for apolipoprotein B-48 (Apo B-48): Apo B-48 level may be a useful marker of coronary heart disease (2006) (0)
A Large Scale Isolation of cDNAs Responsive to Shear Stress from Cultured Human Endothelial Cells (2002) (0)
DPE-025 Serum Oxysterol Levels are Elevated in a Patient with Giant Necrotic Tendon Xanthomatosis and Carotid and Coronary Atherosclerosis(DPE05,Lipid Disorders (H),Digital Poster Session (English),The 73rd Annual Scientific Meeting of The Japanese Circulation Society) (2009) (0)
[A case of familial hypercholesterolemia associated with Basedow's disease]. (1987) (0)
Decreased Cholesterol Efflux from Werner Syndrome Fibroblasts and Its Phenotypic Correction by the Adenovirus-Mediated Gene Delivery of Wild-Type Cdc42 (2003) (0)
LIPOPROTElN METABOLISM IN HYPER-ALPHA-LIPOPROTEINEMIA WITH DEFICIENCY OF CHOLESTERYL ESTER TRANSFER PROTEIN : Arteriosclerosis : 53 Annual Scientific Meeting, Japanese Circulation Society (1989) (0)
Transient severe hyper HDL-cholesterolemia in a case of anorexia nervosa (2002) (0)
Th-P15:86 Fasting serum apolipoprotein B-48 level can be a good marker of postprandial hyperlipidemia and coronary heart disease (2006) (0)
Response of lipoproteins to a meal tolerance test in patients with type 2 diabetes and hypertriglyceridemia (2022) (0)
Abstract 17813: A DPP-4 Inhibitor, Anagliptin, Attenuates Both Fasting and Postprandial Hypertriglyceridemia (2016) (0)
Role of HB-EGF in human atherogenesis (1998) (0)
Clinical Characteristics of Type III Hyperlipoproteinemia in Japan: -In Cases with Apo E2/2 Phenotype-@@@―E2/2 phenotype例における検討― (1985) (0)
W13.330 Vesicular acidification is required for ATP-binding cassette transporter A1-mediated phospholipid and cholesterol efflux (2004) (0)
A Study of High Density Lipoprotein (HDL) Receptors Expressed on a Human Hepatoma Cell Line Mahlavu (1990) (0)
VLDL synthesis and microsomal triglyceride transfer protein (MTP): -Role of MTP in the pathogenesis of hyperlipidemia-@@@―高脂血症の発症過程におけるMTPの役割― (1998) (0)
Studies on the Particle Size of Low Density Lipoprotein and High Density Lipoprotein of Various Hyperlipidemic Subjects by High Performance Liquid Chromatography: ―HPLCによる検討― (1988) (0)
2. Pathophysiology of Atherosclerosis and Its Prevention and Treatment (2019) (0)
Receptor Pathway and Enhanced by Hypoxic Conditions Lipid Accumulation in Smooth Muscle Cells Under LDL Loading Is Independent of LDL (2013) (0)
Dominant Negative Effect of Truncated ATP-Binding Cassette Transporter-1 Mutations on the Clinical Phenotypes and Cellular Cholesterol Efflux in the Heterozygotes (2003) (0)
Extralysosomal degradation of high-density lipoproteins in a human hepatoma cell line, Mahlavu. (1993) (0)
A novel adipocyte-derived plasma protein, adiponectin, inhibits vascular smooth muscle cell proliferation (2000) (0)
patient-oriented and epidemiological research Chylomicron remnants are increased in the postprandial state in CD36 deficiency (2009) (0)
EZETIMIBE MARKEDLY REDUCED SERUM PLANT STEROLS IN JAPANESE PATIENTS WITH SITOSTEROLEMIA (2008) (0)
Abstract 12384: Novel Approach to Residual Risk, K-877, a Potent and Selective PPAR-α Modulator (SPPARMα), Added-on to Pitavastatin in Japanese Patients With Dyslipidemia (2015) (0)
Cerebrovascular diseases. (2014) (0)
C-Reactive Protein-Mediated Low-Density Lipoprotein Uptake by Human Monocyte-Derived Macrophages : Implications in Atherogenesis (2003) (0)
INTRACORONARY NICORANDIL CAN IMPROVE MICROVASCULAR DYSFUNCTION FOLLOWING PRIMARY PERCUTANEOUS CORONARY INTERVENTION IN PATIENTS WITH ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION: ITS SUPERIORITY TO INTRACORONARY NITROGLYCERIN (2010) (0)
A Pooled Analysis of Pemafibrate Phase II/III Clinical Trials Showed No Significant Increase in Incidence of Adverse Events Compared with Placebo (2018) (0)
4.P.246 Contribution of enhanced hepatic acyl-CoA synthetase and microsomal triglyceride transfer protein to the pathogenesis of hyperlipidemia (1997) (0)
4 Adiponectin Accelerates Reverse Cholesterol Transport by Increasing HDL Assembly in the Liver and by Enhancing Cholesterol Efflux from Foam Cells(Hypoalphalipoproteinemia, Its Pathogenesis and Treatments, The 71st Annual Scientific Meeting of the Japanese Circulation Society) (2007) (0)
Strategy for “raising HDL”; HDL-cholesterol or HDL particle numbers insight from cholesteryl ester transfer protein deficiency (2007) (0)
A Case of Homozygous:Familial Hypercholesterolemia Presenting Marked Reduction of Serum Cholesterol Following Treatment with CS-514 (Inhibitor of HMG-CoA Reductase) and Posttransfusion Hepatitis (2011) (0)
Achievement Rates for Low-Density Lipoprotein Cholesterol Goals in Patients at High Risk of Atherosclerotic Cardiovascular Disease in a Real-World Setting in Japan. (2023) (0)
DPP4 inhibitor, anagliptin, ameliorates fasting and postprandial hypertriglyceridemia (2016) (0)
Effect of Long Term Treatment of Four Kinds of Cholesterol Lowering Drugs for Familial Hypercholesterolemia (1986) (0)
WHICH INDEXES OF MICROCIRCULATORY RESISTANCE AFTER PRIMARY PERCUTANEOUS CORONARY INTERVENTION ARE LARGER DECREASED BY INTRACORONARY NICORANDIL? NORMAL INDEX OF MICROCIRCULATORY RESISTANCE LEVEL ? (2011) (0)
1P-0223 Cloning and expression of a novel variant of scavenger receptor class B, type 1 (SRBI), SR-BIII, in human macrophages and atherosclerotic lesions (2003) (0)
MS54 SERUM APOLIPOPROTEIN B-48 LEVEL IS CORRELATED WITH CAROTID INTIMA-MEDIA THICKNESS (IMT) IN SUBJECTS WITH NORMAL SERUM TRIGLYCERIDE LEVEL (2010) (0)
2. Evidence of Lipid Intervention in Japanese (2009) (0)
[Progress in the diagnosis of endocrine and metabolic disorders: hyperlipidemia]. (1995) (0)
Denatured LDL Observed in Human Plasma: -A Study of Lipoprotein Metabolism in Steroid Sulfatase Deficiency-@@@―Steroid Sulfatase欠損症におけるリポ蛋白代謝の検討― (1986) (0)
Novel Selective PPARα Modulator Pemafibrate for Dyslipidemia, Nonalcoholic Fatty Liver Disease (NAFLD), and Atherosclerosis (2023) (0)
Abstract 20865: Experience From the First-in-Human Case--A Phase I Clinical Trial Evaluating the Safety of Allogeneic Adipose Tissue-Derived Multilineage Progenitor Cells-Transplantation Therapy in Severe Familial Hypercholesterolemia Patients (2016) (0)
[Trends toward development of other novel antihyperlipidemic drugs]. (2002) (0)
region : the ' ' Ten Countries Study ' ' primary care physicians in the Asia-Pacific familial hypercholesterolaemia among and preferences concerning the care of questionnaire into knowledge , awareness An enquiry based on a standardised (2017) (0)
The Role of Microsomal Triglyceride Transfer Protein (MTP) in the Mechanism of Hyperlipidemia Under Overnutrition State (2011) (0)
The Significance of Cholesteryl Ester Transfer Protein and Hepatic Triglyceride Lipase Activities in the Pathogenesis of Familial Hyperalphalipoproteinemia (1990) (0)
PE-043 Defective Cholesterol Efflux Increased Lipid Rafts and Enhanced Lipopolysaccharide-induced Cytokine Release(Atherosclerosis, basic-3 (H) PE8,Poster Session (English),The 70th Anniversary Annual Scientific Meeting of the Japanese Circulation Society) (2006) (0)
The role of TTC39B in atherosclerosis and non-alcoholic steatohepatitis. (2017) (0)
P346 APOB48/TG RATIO IS A NOVEL AND USEFUL MARKER FOR THE DETECTION OF TYPE III HYPERLIPIDEMIA AFTER ANTIHYPERLIPIDEMIC INTERVENTIONS (2010) (0)
Abstract: P416 FENOFIBRATE REDUCES POSTPRANDIAL HYPERTRIGLYCERIDEMIA IN CD36-DEFICIENT MICE (2009) (0)
Long-Term Treatment With Evolocumab Among Japanese Patients ― Final Report of the OSLER Open-Label Extension Studies ― LATE BREAKING CLINICAL TRIAL (JCS 2019) (2019) (0)
PO2-36 POSTPRANDIAL HYPERTRIGLYCERIDEMIA IN CD36 DEFICIENCY IS CAUSED BY AN ACCELERATED LIPOPROTEIN SYNTHESIS IN THE SMALL INTESTINES (2007) (0)
Effect of Minocycline for Patients with Active Takayasu Arteritis : Long-Term Follow Up Study (2003) (0)
PJ-035 Serum Apolipoprotein B-48 Level is Correlated with Intima-Media Thickness of Carotid Arteries in Subjects with Normal Serum Triglyceride Level(PJ006,Lipid Disorders (H),Poster Session (Japanese),The 73rd Annual Scientific Meeting of The Japanese Circulation Society) (2009) (0)
[Clinical significance of primary and secondary prevention trials with lipid-lowering therapy against coronary heart disease]. (2001) (0)
PE-254 Pitavastatin Improved Postprandial Hypertriglyceridemia Caused by the Accelerated Intestinal Lipid Absorption in Cd36 Deficiency(Lipid disorders-2, The 71st Annual Scientific Meeting of the Japanese Circulation Society) (2007) (0)
2P-0450 Identification of a novel mutation in the ATP-binding cassette transporter G5 (ABCG5) in a Japanese patient with sitosterolemia (2003) (0)
Impaired efflux of cholesterol from aged cells and its molecular mechanism: A basis for age‐related enhancement of atherosclerosis (2007) (0)
PO18-513 CD36 DEFICIENCY IS ASSOCIATED WITH PHENOTYPES OF THE METABOLIC SYNDROME AND ENHANCED ATHEROSCLEROTIC CARDIOVASCULAR DISEASES (2007) (0)
Effect of niacin on oxidized low-density lipoprotein levels in Chinese patients with dyslipidaemia (2014) (0)
Mo-W9:6 Familial intrahepatic cholestasis 1 gene product, a novel contributor for cholesterol efflux (2006) (0)
A CROSS OVER STUDY, BENEFICIAL EFFECT OF INTRACORONARY NICORANDIL, A HYBRID K-ATP CHANNEL OPENER AND NITRIC OXIDE DONOR, ON MICROVASCULAR DYSFUNCTION IN PATIENTS WITH ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION: DEMONSTRATION OF ITS SUPERIORITY TO INTRACORONARY NITROGLYCERIN (2011) (0)
Abstract: P430 ROLE OF ADIPONECTIN IN THE ATHEROPROTECTIVE SYSTEM VIA HDL-CHOLESTEROL (2009) (0)
A Molecular Mechanism Underlying Cdc42-Mediated Cholesterol Efflux from the Cells (2003) (0)
Gaps in beliefs and practice in dyslipidaemia management in Japan, Germany, Colombia and the Philippines: insights from a web-based physician survey (2020) (0)
Erratum to: fasting remnant lipoproteins can predict postprandial hyperlipidemia (2014) (0)
3.P.253 Localization of CD9, an enhancer protein for proHeparin-binding EGF-like growth factor, in atherosclerotic plaques (1997) (0)
OE-079 HDL-mediated Plaque Stabilization through Enhancement of Cholesterol Efflux and Inhibition of a Novel Proinflammatory Cytokine Proepithelin(Atherosclerosis, basic-1, The 71st Annual Scientific Meeting of the Japanese Circulation Society) (2007) (0)
Serum Matrix Metalloproteinases (MMPs) Levels Are Diagnostic Markers of Active Phase in Patients with Takayasu Arteritis (2002) (0)
4.P.363 Two novel mutations of cholesteryl ester transfer protein (CETP) gene in Japanese hyperalphalipoproteinemic patients (1997) (0)
Abstract: P410 EZETIMIBE IMPROVES POSTPRANDIAL HYPERLIPIDEMIA IN PATIENTS WITH TYPE IIB HYPERLIPIDEMIA (2009) (0)
P343 FATTY ACIDS DERIVATIVES BY LIPID PEROXIDATION ARE SIGNIFICANTLY INCREASED IN PATIENTS WITH HIGH APOLIPOPROTEIN B-48 LEVELS, INDEPENDENT OF TRIGLYCERIDE CONCENTRATIONS (2010) (0)
Mutation of the Low Density Lipoprotein Receptor in Homozygous Familial Hypercholesterolemia: Analysis by Monoclonal Antibody (1987) (0)
3P-0751 Postprandial hyperlipidemia and increased remnant lipoproteins in human genetic CD36 deficiency (2003) (0)
Premature replicative senescence in skin fibroblasts from Tangier disease (2002) (0)
Eicosapentaenoic acid ameriolates postprandial hypertriglyceridemia (2014) (0)
Serum Values of Cholesterol Absorption and Synthesis Biomarkers in Japanese Healthy Subjects: The CACHE Study HEALTHY Analysis. (2023) (0)
Abstract 12669: Effect of Probucol on Antioxidant Properties of HDL in Patients with Heterozygous Familial Hypercholesterolemia (2011) (0)
PLATELET LIPID COMPOSITION IN PATIENTS WITH ATHEROSCLEROTIC DISEASE : PROCEEDINGS OF THE 47th ANNUAL SCIENTIFIC MEETING OF THE JAPANESE CIRCULATION SOCIETY : Myocardial Metabolism Biochemistry (1983) (0)
Long-term Effects of Probucol Treatment for Heterozygous Familial Hypercholesterolemia, on Serum Lipid and Lipoprotein Levels and Regression of Xanthomas and Coronary Atherosclerosis (1991) (0)
P354 A NOVEL HDL-ASSOCIATED PROTEIN, PROGRANULIN, IS INVOLVED IN LIPID METABOLISM AND MACROPHAGE RECRUITMENT INTO ADIPOSE TISSUES (2010) (0)
Prevalence of coronary artery disease and achievement of low-density lipoprotein cholesterol management targets in familial hypercholesterolemia patients at Osaka University Hospital (2020) (0)
-0378-DEMONSTRATION OF TWO SPECIES OF LDL PARTICLES IN PATIENTS WITH CHOLESTERL ESTER TRANSFER PROTEIN (CETP) DEFICIENCY (1990) (0)
ADIPONECTIN ENHANCES APOA-1- AND HDL- MEDIATED CHOLESTEROL EFFLUX FROM HUMAN MONOCYTE-DERIVED MACROPHAGES (2008) (0)
How a receptor for oxidized low density lipoproteins works in human : Insights from human genetic CD36 deficiency (2002) (0)
Enhanced Intestinal Absorption of Cholesterol along with Increased Chylomicron Remnants for De novo Progression of Coronary Stenosis (2017) (0)
4.P.350 Mutational analysis of hyperalphalipoproteinemia (HALP) in the Japanese: Cholesteryl ester transfer protein deficiency contributes about 60% of marked HALP (1997) (0)
Abstract 20486: Noninvasive Regional Cerebral Oxygen Saturation Can Predict Poor Brain Resuscitation in Patients with Out-of-Hospital Cardiac Arrest (2010) (0)
[Molecular mechanism of atherogenesis in hyperlipidemia]. (2007) (0)
Abstract 18976: A Role of an HDL-associated Anti-inflammatory Protein, Progranulin, in Acute Coronary Syndrome (2014) (0)
[Case of homozygous familial hypercholesterolemia in a family known for longevity]. (1983) (0)
Increased myocardial FDG uptake in CD36-deficient mice detected by means of high resolution semiconductor PET (2010) (0)
Chronic kidney disease. (2014) (0)
Fasting remnant lipoproteins can predict postprandial hyperlipidemia (2012) (0)
W08-P-010 Apolipoprotein B-100 kinetics and plasma markers of triglyceride-rich lipoprotein particle concentrations in overweight men (2005) (0)
Importance of Early Diagnosis and Treatment of Familial Hypercholesterolemia in Health Examination: Messages from the Japan Atherosclerosis Society (2017) (0)
Diagnostic criteria for screening dyslipidemia and lipid management targets from the point of preventive medicine (2015) (0)
Effect of a Novel Shear Stress Inducible Rho Small GTPase on the Cytoskeleton Systems and Permeability of Human Endothelial Cells (2003) (0)
Abstract 16198: Ttc39b Deficiency Causes an Intestinal Lxr Activation Phenotype With Increased Expression Of Abca1 and HDL-Cholesterol Levels (2013) (0)
PE-444 Relation of Remnant Lipoprotein Cholesterol Levels Determined by Three Different Methods to Visceral Fat Accumulation(Diabetes/Obesity/Metabolic syndrome-5 (H) PE74,Poster Session (English),The 70th Anniversary Annual Scientific Meeting of the Japanese Circulation Society) (2006) (0)
Significance of measuring serum apolipoprotein (apo) B-48 concentrations in evaluating the metabolism of chylomicrons and chylomicron remnants (2002) (0)
[Functional disorders of lipid transfer proteins]. (2007) (0)
[Molecular biology of reverse cholesterol transport system and impairment of the protection system against atherosclerosis]. (1993) (0)
Lipids / Lipoproteins Wednesday , August 2 , 9 : 30 am – 5 : 00 pm B-139 Multicenter Evaluation of new HDL-Cholesterol Generation 4 assay ( HDLC 4 ) on Roche Clinical Chemistry Analyzers (2017) (0)
Coronary Artery Disease and Lipoprotein Abnormalities in Patients with Heterozygous Familial Hypercholesterolemia Associated with Diabetes Mellitus or Impaired Glucose Tolerance (1992) (0)
A 31-Year-Old Woman with Homozygous Hypercholesterolemia without Significant in the Coronary Arteries Familial Lesions (1986) (0)
A Possible Major Source of Plasma HDL Particles : Role of ATP Binding Cassette A1 (ABCA1) in Human Intestines (2003) (0)
Association of Serum Levels of Cholesterol Absorption and Synthesis Markers with the Presence of Cardiovascular Disease: The CACHE Study CVD Analysis (2023) (0)
LDL Cholesterol : The Lower the Better? (2003) (0)
Abdoninal Fat:Standardized Technique for Mesurement at CT (2004) (0)
DISTAL PROTECTION CAN PRESERVE INDEX OF MICROCIRCULATORY RESISTANCE IN PATIENTS WITH ST-SEGMENT ELEVATION ANTERIOR WALL MYOCARDIAL INFARCTION (2010) (0)
Chapter 1 – Molecular Mechanisms of Hyperalphalipoproteinemia (2017) (0)
Abstract 16539: Visualization and Quantification of FDG Uptake in Myocardium of CD36-Knockout Mice in vivo Using a Novel High Spatial Resolution Semiconductor PET (2010) (0)
PJ-646 Usefullnes of "Off-pump Trial" and "Volume-loading Trial" : To Identify Who Could be Weaned from Left Ventricular Assist Device(PJ109,Heart Failure (Treatment) 3 (M),Poster Session (Japanese),The 73rd Annual Scientific Meeting of The Japanese Circulation Society) (2009) (0)
3.P.175 CD36 is expressed in atherosclerotic lesion and its expression is upregulated by oxidized LDL (1997) (0)
Combination of Neutrophil‐to‐Lymphocyte and Platelet‐to‐Lymphocyte Ratios as a Novel Predictor of Cardiac Death in Patients With Acute Decompensated Heart Failure With Preserved Left Ventricular Ejection Fraction: A Multicenter Study (2022) (0)
[Congenital hypoalphalipoproteinemia]. (1998) (0)
Age-related decline of the expression of a Rho GTPases family, CDC42Hs, in human skin fibroblasts in association with reduction of HDL-mediated cholesterol efflux (2000) (0)
XCR1+ conventional dendritic cell-induced CD4+ T helper 1 cell activation exacerbates cardiac remodeling after ischemic myocardial injury. (2023) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Shizuya Yamashita?

Shizuya Yamashita is affiliated with the following schools:

Shizuya Yamashita's Academic­Influence.com Rankings

Shizuya Yamashita's Degrees

Similar Degrees You Can Earn

Why Is Shizuya Yamashita Influential?

Shizuya Yamashita's Published Works

Published Works

What Schools Are Affiliated With Shizuya Yamashita?

Shizuya Yamashita's AcademicInfluence.com Rankings